The Value of Dual-parametric Magnetic Resonance Combined With Regional Saturation Biopsy in Patients With Suspected Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 14, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2029

Conditions
Prostate Cancer
Interventions
PROCEDURE

Follow up if MRI is negative

Enter the follow-up cohort without systematic biopsy when prostate cancer is clinically suspected and no PIRADS v2.1 score ≥3 lesions are detected on initial examination. MR plus regional saturation biopsy was performed when MRI progressed.

PROCEDURE

Systematic biopsy if MRI is negative

Systematic biopsy was performed if there was clinical suspicion of prostate cancer and no PIRADS v2.1 score ≥3 lesions were detected on initial examination. If the biopsy was negative enter the follow-up cohort.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER